CVS Health Co. (NYSE:CVS) Shares Purchased by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC grew its stake in CVS Health Co. (NYSE:CVS - Free Report) by 14.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,668 shares of the pharmacy operator's stock after buying an additional 8,198 shares during the quarter. Motley Fool Asset Management LLC's holdings in CVS Health were worth $2,948,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Ridgewood Investments LLC lifted its stake in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC bought a new position in CVS Health in the 4th quarter valued at about $28,000. Hopwood Financial Services Inc. bought a new stake in CVS Health during the fourth quarter worth $29,000. Legacy Investment Solutions LLC bought a new position in CVS Health in the third quarter valued at about $31,000. Finally, Financial Perspectives Inc boosted its position in CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after buying an additional 466 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The stock was purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of the business's stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CVS shares. Wells Fargo & Company boosted their price target on shares of CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Mizuho lifted their price target on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday. Piper Sandler upped their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. JPMorgan Chase & Co. increased their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 18th. Finally, Wolfe Research raised their target price on CVS Health from 67.00 to 70.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and an average target price of $70.94.

CVS Health Stock Performance

Shares of NYSE CVS traded up $2.77 during midday trading on Wednesday, reaching $70.40. 17,720,174 shares of the company were exchanged, compared to its average volume of 11,712,207. The stock has a fifty day simple moving average of $64.58 and a 200 day simple moving average of $58.35. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $73.18. The stock has a market cap of $88.76 billion, a P/E ratio of 19.24, a PEG ratio of 0.98 and a beta of 0.57. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.78%. The ex-dividend date is Tuesday, April 22nd. CVS Health's dividend payout ratio is presently 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.